Filter
7256
Filtered Results: 7256
Text search:
Partners
in
Health,
World
Health
Organization
Featured
Recommendations
617
New Publications
2088
Language
Document type
No document type
4213
Studies & Reports
1175
Guidelines
793
Manuals
366
Strategic & Response Plan
327
Fact sheets
119
Training Material
107
Situation Updates
86
Resource Platforms
27
Brochures
15
Infographics
14
Online Courses
6
Videos
5
App
2
Dashboards/Maps
1
Countries / Regions
Global
319
India
238
Kenya
226
Sierra Leone
189
Uganda
175
Ethiopia
173
Nigeria
166
Liberia
158
Nepal
138
Myanmar / Burma
127
Zambia
121
South Africa
115
Rwanda
114
Bangladesh
109
Malawi
108
Syria
106
Africa
106
Tanzania
106
Western and Central Europe
104
Ghana
94
Ukraine
82
Congo, Democratic Republic of
81
South Sudan
76
Namibia
74
Latin America and the Carribbean
69
Philippines
66
Lesotho
56
Zimbabwe
56
Cambodia
54
South–East Asia Region
50
Guinea
49
Indonesia
48
Mozambique
47
Asia
47
Haiti
45
Yemen
42
Eastern Europe
41
Senegal
39
East and Southern Africa
38
West and Central Africa
37
Cameroon
34
Afghanistan
32
Botswana
31
Middle East and North Africa
30
Burkina Faso
28
Germany
28
Pakistan
26
Russia
24
Central African Republic
24
Somalia
22
Jordan
20
Lebanon
20
Eswatini/ Swaziland
20
Brazil
19
Mali
19
Thailand
18
Venezuela
18
Western Pacific Region
17
Sudan
17
Madagascar
17
Benin
15
Eastern Europe and Central Asia
15
Iraq
15
Colombia
14
Vietnam
14
Tajikistan
13
Laos
12
Moldova
12
Sri Lanka
12
China
10
Albania
10
Côte d’Ivoire / Ivory Coast
10
Georgia
9
Angola
9
Libya
9
Turkey
8
Togo
8
Niger
8
Chad
8
North Macedonia
7
Timor Leste/ East Timor
7
Gambia
7
Iran
7
Burundi
7
Peru
6
USA
6
North America
6
Palestine
6
Mexico
5
Kyrgyzstan
5
Guinea-Bissau
5
Jamaica
5
Papua New Guinea
5
Egypt
5
Greece
5
Poland
5
Serbia
4
Kazakhstan
4
Armenia
4
Turkmenistan
4
Japan
4
Southern Africa
4
Romania
4
Honduras
4
El Salvador
3
Malaysia
3
Morocco
3
Mauritania
3
Croatia
3
Hungary
3
Paraguay
3
Mauritius
3
Tunisia
3
Portugal
3
Spain
3
Belarus
3
Bhutan
3
Guatemala
3
North Korea
2
Switzerland
2
Canada
2
Bulgaria
2
Italy
2
Dominican Republic
2
Saudi Arabia
2
United Kingdom
2
Azerbaijan
2
Israel
2
Bolivia
2
Argentina
2
Djibouti
2
Chile
1
Fiji
1
Singapore
1
Estonia
1
Uzbekistan
1
Austria
1
Vanuatu
1
Mongolia
1
Qatar
1
Cape Verde
1
Lithuania
1
Gabon
1
Denmark
1
Belgium
1
Maldives
1
Norway
1
Algeria
1
Bosnia and Herzegovina
1
Latvia
1
Belize
1
Costa Rica
1
Panama
1
Nicaragua
1
Slovakia
1
Ecuador
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2726
Key Resources
490
Clinical Guidelines
419
Women & Child Health
416
Public Health
365
Capacity Building
133
Pharmacy & Technologies
46
Annual Report MEDBOX
3
Toolboxes
HIV
693
COVID-19
489
Mental Health
429
TB
341
Disability
305
Conflict
263
Ebola & Marburg
246
Planetary Health
231
Rapid Response
228
NTDs
179
Caregiver
174
AMR
169
Refugee
149
Global Health Education
143
Health Financing Toolbox
105
Natural Hazards
99
Pharmacy
83
Malaria
80
Zika
74
NCDs
71
Cholera
50
Polio
42
Specific Hazards
26
Social Ethics
22
2.0 Rapid Response
10
Typhoon
3
South Sudan
2
The purpose of this Guide is to set out a simple, user-friendly, step-by-step approach for conducting table-top exercises for use in countries. These are generic guidelines which may be adapted for use at all levels in a country.
his document, a first of its kind, clearly sets out the standards for rehabilitation and provides guidance on building or strengthening the capacity of EMTs in this area.The importance of early rehabilitation for functional outcomes is well documented. Rehabilitation needs can pe...
It is estimated that more than 311 000 women die of cervical
cancer each year. Of these deaths, 91% occur in low- and
middle-income countries. Demographic changes and a lack of
action mean that the number of deaths per year is projected
to reach 460 000 by 2040.
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
Improving access to assistive technology for everyone, everywhere.
The first WHO Priority Assistive Products List was launched in May 2016. The List includes hearing aids, wheelchairs, communication aids, spectacles, artificial limbs, pill organizers, memory aids and other essential items for many...
The WHO European Office for the Prevention and Control of Noncommunicable Diseases organized an expert meeting on monitoring of digital marketing of unhealthy products to children and adolescents in June 2018. Based on that meeting, this report aims to provide a tool to support Member States in moni...
The HIV drug resistance report 2021 summarizes findings from 38 countries that had finalized the surveys by the time of this report and shared data with WHO.
Pretreatment HIVDR to non-nucleoside reverse-transcriptase inhibitors (NNRTI) can affect more than 10% of adults starting therapy and is fo...
Enabling young children to achieve their full developmental potential is a human right and an essential requisite for sustainable development. Given the critical importance of enabling children to make the best start in life, the health sector, among other sectors, has an important role and responsi...
Ramped-up cancer services could save 7 million lives over the next decade—and addressing huge service gaps between rich and poor countries is key to success, according to this report.
In 2019, over 90% of high-income countries reported that comprehensive cancer treatment services were available...
Mpox, previously known as monkeypox, is a viral illness caused by the monkeypox virus (MPXV).1
It causes a painful rash, enlarged lymph nodes, fever, headache, muscle ache, back pain and low energy or feeling sick. In most cases, the symptoms of mpox go away within a few weeks with supportive care...
WHO TRS N°1012.
Key updates include: (i) surveillance strategies, including cross-sectoral linking of systems and suitable diagnostics; (ii) the latest recommendations on human and animal immunization; (iii) palliative care in lowresource settings; (iv) risk assessment to guide management of bite...
Antimicrobial Resistance Resource Platform
recommended
Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi.
AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections ha...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
9 March 2022, Timely and accurate diagnostic testing for SARS-CoV-2 is an essential part of a comprehensive COVID-19 response strategy. Ag-RDTs can be performed by individuals in which they collect their own specimen, perform a simple rapid test and interpret their test result themselves at a time a...
Zika virus is primarily transmitted by the Aedes species of mosquito which is also responsible for the spread of dengue, Chikungunya and yellow fever viruses. In most areas, the primary vector of these viruses is Aedes aegypti, with Aedes albopictus a proven or potential vector in some settings. Wel...
This document provides interim recommendations for the surveillance of Zika virus infection, microcephaly and Guillain-Barré syndrome, in four different contexts and describes reporting requirements to WHO. Transmission refers to vector-borne transmission, unless specified differently. Autochthonou...
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas...
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
